How are you using ArteraAI in 2026 for intermediate risk patients?
ArteraAI has now been around for a while. Wondering how many people are ordering this routinely in intermediate risk patients and whether people are comfortable making ADT and AS decisions based on the results.
Community PollStarted
How are you using ArteraAI for intermediate risk patients in 2026?
215 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC
Answered on
I use both ArteraAI and Decipher to help with these decisions. As Dr. @Dr. First Last says, it's post-hoc based on large datasets. Artera claims to be predictive, while Decipher is just prognostic.
Without going through all the data, I find it helpful for intermediate risk, where it is on the cusp o...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center
Answered on
Personally, I have not used ArteraAI to guide treatment decisions. None of the advanced prognostic tools of this nature have been prospectively evaluated. Consequently, I am reluctant to use them to influence treatment decisions at this time. The post hoc meta-analyses are promising, and hopefully, ...
Join for free or sign in to see the full answer